Panaxatriol saponins exert anti-renal fibrosis by suppressing TNF-α mediated inflammation and TGF-β1/Smad3 signaling pathway
Renal fibrosis is a key pathological process in the progression of chronic kidney disease (CKD). Panaxatriol saponins (PTS), the main bioactive compounds extracted from Panax notoginseng (Burk.) F.H. Chen, have demonstrated antioxidative and anti-inflammatory activities. This study aimed to investig...
| Published in: | Renal Failure |
|---|---|
| Main Authors: | Si Yi, Feiyan Li, Xin Ma, Yao Xu, Weijing Lai, Hongxi Chen, Junming Fan, Nan Mao, Sichong Ren |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2516774 |
Similar Items
The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats
by: Yanwei Wang, et al.
Published: (2024-09-01)
by: Yanwei Wang, et al.
Published: (2024-09-01)
Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
by: Hui Wang, et al.
Published: (2022-12-01)
by: Hui Wang, et al.
Published: (2022-12-01)
The anti-platelet activity of panaxadiol fraction and panaxatriol fraction of Korean Red Ginseng in vitro and ex vivo
by: Yuan Yee Lee, et al.
Published: (2023-09-01)
by: Yuan Yee Lee, et al.
Published: (2023-09-01)
Saponins from Panax japonicus ameliorate age-related renal fibrosis by inhibition of inflammation mediated by NF-κB and TGF-β1/Smad signaling and suppression of oxidative stress via activation of Nrf2-ARE signaling
by: Yan Gao, et al.
Published: (2021-05-01)
by: Yan Gao, et al.
Published: (2021-05-01)
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
by: Panpan Wang, et al.
Published: (2020-06-01)
by: Panpan Wang, et al.
Published: (2020-06-01)
Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials
by: Lulu Dai, et al.
Published: (2022-12-01)
by: Lulu Dai, et al.
Published: (2022-12-01)
Paridis Rhizoma Saponins ameliorate CCl4-induced liver fibrosis via modulation of the Nrf2-HO-1/NQO-1 and TGF-β1/Smads signaling pathways
by: Yan Hong, et al.
Published: (2025-06-01)
by: Yan Hong, et al.
Published: (2025-06-01)
TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)
Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01)
by: Feng Xie, et al.
Published: (2014-10-01)
Ellagic Acid Inhibits TGFβ1/Smad-Induced Renal Fibrosis in Diabetic Kidney Injury
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)
by: Ozkan Gorgulu, et al.
Published: (2022-12-01)
The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment
by: Feilong Chen, et al.
Published: (2025-09-01)
by: Feilong Chen, et al.
Published: (2025-09-01)
Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01)
by: Qian Huang, et al.
Published: (2022-09-01)
Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01)
by: Qian Huang, et al.
Published: (2024-12-01)
SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
by: Qi Song, et al.
Published: (2024-12-01)
by: Qi Song, et al.
Published: (2024-12-01)
The promotive role of reticulocalbin 3 (RCN3) in the pathogenesis of keloid via TGFβ1/Smad2/Smad7 signaling pathway in vitro
by: Wang HongYu, et al.
Published: (2024-12-01)
by: Wang HongYu, et al.
Published: (2024-12-01)
SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis
by: Meng Tu, et al.
Published: (2024-10-01)
by: Meng Tu, et al.
Published: (2024-10-01)
Environmentally relevant concentration PFNA promotes degradation of SMAD7 to drive progression of ovarian cancer via TGF-β/SMADs signaling pathway
by: Jiamin Zhong, et al.
Published: (2024-10-01)
by: Jiamin Zhong, et al.
Published: (2024-10-01)
Investigation of SMAD3 and SMAD4 Genes Expression in CML Patients and K562 Cell Line
by: T Mahdloo, et al.
Published: (2023-04-01)
by: T Mahdloo, et al.
Published: (2023-04-01)
Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway
by: Ziqing Yu, et al.
Published: (2024-01-01)
by: Ziqing Yu, et al.
Published: (2024-01-01)
Identification of Tisp40 as an Essential Regulator of Renal Tubulointerstitial Fibrosis via TGF-β/Smads Pathway
by: Cheng-cheng Xiao, et al.
Published: (2017-06-01)
by: Cheng-cheng Xiao, et al.
Published: (2017-06-01)
Investigation of The Efficacy of Sericin in Experimental Knee Osteoarthritis Model in Rats through the TGF-Beta/Smad Pathway
by: Gülçin Abban Mete, et al.
Published: (2024-08-01)
by: Gülçin Abban Mete, et al.
Published: (2024-08-01)
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7
by: Chenchen Geng, et al.
Published: (2025-05-01)
by: Chenchen Geng, et al.
Published: (2025-05-01)
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin
by: Guang-Yu Lian, et al.
Published: (2021-03-01)
by: Guang-Yu Lian, et al.
Published: (2021-03-01)
AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats
by: Moustafa Fathy, et al.
Published: (2020-01-01)
by: Moustafa Fathy, et al.
Published: (2020-01-01)
Peroxisome proliferator-activated receptors gama ameliorates liver fibrosis in non-alcoholic fatty liver disease by inhibiting TGF-β/Smad signaling activation
by: Zhang Qingwei, et al.
Published: (2024-04-01)
by: Zhang Qingwei, et al.
Published: (2024-04-01)
Expression of individual members of the TGF-β/SMAD signalling pathway in the progression and survival of patients with colorectal carcinoma
by: Ivana Večurkovská, et al.
Published: (2024-11-01)
by: Ivana Večurkovská, et al.
Published: (2024-11-01)
CLC-3 regulates TGF-β/smad signaling pathway to inhibit the process of fibrosis in hypertrophic scar
by: Qian Liang, et al.
Published: (2024-02-01)
by: Qian Liang, et al.
Published: (2024-02-01)
Effect of aging on the formation and growth of colonic epithelial organoids by changes in cell cycle arrest through TGF-β-Smad3 signaling
by: Min Kyoung Jo, et al.
Published: (2023-07-01)
by: Min Kyoung Jo, et al.
Published: (2023-07-01)
Expression of pelvic organ prolapse-related protein fibulin-5, TGFβ, and Smad2/3 in Uyghur women of Xinjiang
by: Shaadaiti Wufuer, et al.
Published: (2021-04-01)
by: Shaadaiti Wufuer, et al.
Published: (2021-04-01)
Differential regulation of TGF-β/Smad signaling in hepatic stallate cells between acute and chronic liver injuries
by: Katsunori eYoshida, et al.
Published: (2012-03-01)
by: Katsunori eYoshida, et al.
Published: (2012-03-01)
The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway
by: Guoguo Wan, et al.
Published: (2023-02-01)
by: Guoguo Wan, et al.
Published: (2023-02-01)
Effects of E. Coli Infection on the Expressions of TGF-β/Smads Signaling Pathway in Broiler Intestine
by: J Juang, et al.
by: J Juang, et al.
Aspirin attenuates the detrimental effects of TNF-α on BMMSC stemness by modulating the YAP-SMAD7 axis
by: Xudong Wang, et al.
Published: (2024-08-01)
by: Xudong Wang, et al.
Published: (2024-08-01)
Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
by: Zhi-Hao Zhang, et al.
Published: (2018-09-01)
by: Zhi-Hao Zhang, et al.
Published: (2018-09-01)
miR-21 and miR-155 in the regulation of TGF-β1/SMAD signaling pathway of the line breast cancer cells with different metastatic potential
by: Z. N. Nikiphorova, et al.
Published: (2015-09-01)
by: Z. N. Nikiphorova, et al.
Published: (2015-09-01)
Association between Altered Expression and Genetic Variations of Transforming Growth Factor β-Smad Pathway with Chronic Myeloid Leukemia
by: Yogender Shokeen, et al.
Published: (2018-01-01)
by: Yogender Shokeen, et al.
Published: (2018-01-01)
Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling
by: Guoqian Liu, et al.
Published: (2024-04-01)
by: Guoqian Liu, et al.
Published: (2024-04-01)
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01)
by: Lijie Yang, et al.
Published: (2025-01-01)
GNMT inhibits intrauterine adhesion fibrosis through TGF-β1/Smad3 signaling pathway and its mechanism
by: GU Hong, et al.
Published: (2024-09-01)
by: GU Hong, et al.
Published: (2024-09-01)
Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition
by: Qun Yu, et al.
Published: (2022-05-01)
by: Qun Yu, et al.
Published: (2022-05-01)
Similar Items
-
The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats
by: Yanwei Wang, et al.
Published: (2024-09-01) -
Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
by: Hui Wang, et al.
Published: (2022-12-01) -
The anti-platelet activity of panaxadiol fraction and panaxatriol fraction of Korean Red Ginseng in vitro and ex vivo
by: Yuan Yee Lee, et al.
Published: (2023-09-01) -
Saponins from Panax japonicus ameliorate age-related renal fibrosis by inhibition of inflammation mediated by NF-κB and TGF-β1/Smad signaling and suppression of oxidative stress via activation of Nrf2-ARE signaling
by: Yan Gao, et al.
Published: (2021-05-01) -
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
by: Panpan Wang, et al.
Published: (2020-06-01)
